Clinical Trial Update: Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

View source ↗

Summary

A National Institute of Allergy and Infectious Diseases-sponsored study of autoimmune lymphoproliferative syndrome (ALPS) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Lymphoproliferative Syndrome

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Benign Lymphoproliferative Disorder | Status: RECRUITING